Events

Recall of TAPERED SCREW-VENT IMPLANT WIDE HA 4.1-4.7MM D

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ZIMMER BIOMET DENTAL CANADA INC. / ZIMMER BIOMET DENTAIRE CANADA INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    64142
  • Event Risk Class
    III
  • Event Initiated Date
    2014-10-07
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Zimmer dental is conducting a recall of a single lot of the tapered screw-vent implant catalog tsv4b11 because the inner vial could be potentially mislabeled as "04.1 x 10mml" instead of "04.1 x 11.5mml". the main label on the outside of the package the outer vial label the cap label and the patient chart label contain the correct information regarding the implant within the package.

Device

TAPERED SCREW-VENT IMPLANT WIDE HA 4.1-4.7MM D

Manufacturer

ZIMMER BIOMET DENTAL CANADA INC. / ZIMMER BIOMET DENTAIRE CANADA INC.
  • Manufacturer Address
    MISSISSAUGA
  • Manufacturer Parent Company (2017)
    Zimmer Biomet Holdings
  • Manufacturer comment
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    HC